Peginterferon Alfa-2a for Chronic Myeloid Leukemia in Pregnancy: A Case Report
Journal of the Advanced Practitioner in Oncology · 09.11.2026 · 17 (7)
DOI: 10.6004/jadpro.2026.17.7.34 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 09.11.2026. Verfasst von Thuy Tran und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Tyrosine kinase inhibitors (TKIs), the standard treatment for chronic phase chronic myeloid leukemia (CP-CML), are generally avoided during pregnancy because of teratogenic risk. Peginterferon alfa-2a may be used when treatment is required, although pregnancy data are limited. This case discusses a 31-year-old woman at 8 weeks’ gestation who was diagnosed with CP-CML after presenting with leukocytosis and thrombocytosis. She began peginterferon alfa-2a 90 µg weekly and maintained an adequate hematologic response with mild transaminitis, ultimately delivering a healthy infant. She transitioned to dasatinib postpartum. This case supports peginterferon alfa-2a as a potential option for hematologic control of CP-CML during pregnancy when TKIs are avoided.
Zitieren
APA
Tran, T., PharmD, BCOP, CSP, McElwee, J., PharmD, BCOP, Arnall, J. R., PharmD, BCOP, FCCP, Ragon, B. K., & MD (2026). Peginterferon Alfa-2a for Chronic Myeloid Leukemia in Pregnancy: A Case Report. Journal of the Advanced Practitioner in Oncology, 17(7). https://doi.org/10.6004/jadpro.2026.17.7.34
Vancouver
Tran T, PharmD, BCOP, CSP, McElwee J, PharmD, et al. Peginterferon Alfa-2a for Chronic Myeloid Leukemia in Pregnancy: A Case Report. Journal of the Advanced Practitioner in Oncology. 2026;17(7). doi:10.6004/jadpro.2026.17.7.34
BibTeX
@article{Tran2026,
author = {Tran, Thuy and PharmD and BCOP and CSP and McElwee, Jessica and PharmD and BCOP and Arnall, Justin R. and PharmD and BCOP and FCCP and Ragon, Brittany Knick and MD},
title = {Peginterferon Alfa-2a for Chronic Myeloid Leukemia in Pregnancy: A Case Report},
journal = {Journal of the Advanced Practitioner in Oncology},
year = {2026},
volume = {17},
number = {7},
doi = {10.6004/jadpro.2026.17.7.34}
}
EUVIMED